Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

Influenza and respiratory syncytial virus are the major respiratory viruses detected from prospective testing of pediatric and adult coronial autopsies.

To ascertain the full mortality of influenza and other respiratory viruses, the testing of community autopsy specimens is essential.

METHODS: Respiratory virus PCR and culture were performed on 2418 fresh unfrozen respiratory samples collected from 1611 coronial cases where the death was either unknown or infection was suspected, from July 2007 to June 2011, to detect the common respiratory viruses in children and adults, using standardized microbiological testing.

RESULTS: The respiratory virus positive rate was 8·3% (134 cases) with a peak of 28% (42 of 151 cases) in children under 10 years of age. Influenza virus was the commonest respiratory virus (50 cases, 3%), followed by respiratory syncytial virus (RSV) (30 cases, 2%). All tested respiratory viruses were found in children, most commonly adenovirus, enterovirus and RSV, and influenza A and RSV predominated in those over 60 years, but coinfection was uncommon. Almost all influenza cases occurred when influenza was widely circulating in the community but few were diagnosed pre-mortem. Influenza and RSV detection was associated with bronchitis or bronchiolitis in 7 (9%) of the 80 cases and caused pneumonia in 14 (0·8%) deaths overall.

CONCLUSIONS: Our prospective review of respiratory viruses using standardized testing found a single lower respiratory tract autopsy specimen for respiratory virus PCR would detect most community infections at the time of death.

Effectiveness of Pneumococcal Conjugate Vaccine in Infants by Maternal Influenza Vaccination Status.

Related Articles

Influenza virus infection can predispose patients to secondary pneumococcal infections. Children are at greatest risk for pneumococcal infection in the first year of life, and are not considered fully protected by PCV until their third dose at 6 months of age. Infants less than 6 months cannot receive influenza vaccination, though maternal influenza vaccination can protect infants.

METHODS:: We conducted a retrospective cohort study of 9,807 mother-infant pairs enrolled in a managed care organization for infants born June 1, 2002-Dec. 31, 2009. Exposure was assessed for receipt of infant pneumococcal vaccine (PCV) only, and the combination of PCV and maternal influenza vaccine (TIV). Outcomes of interest were acute otitis media (AOM) and medically attended acute respiratory infection (MAARI) in the first year of life. We estimated the adjusted incidence of illness, incidence rate ratios, and vaccine effectiveness using the ratio of incidence rate ratios between the periods of non-circulating influenza and that of at least local influenza circulation.

RESULTS:: For MAARI, vaccine effectiveness for the combination of TIV and PCV was 39.6% (95% CI: 31.6% , 46.7%) and for PCV only was 29.8% (95% CI: 11.4% , 44.3%). For AOM vaccine effectiveness for the combination of TIV and PCV was 47.9% (95% CI: 42% , 53.3%) and for PCV only was 37.6% (95% CI: 23.1% , 49.4%).

CONCLUSION:: In infants, the combination of maternal influenza vaccine and infant pneumococcal conjugate vaccination confers greater protection from acute otitis media infections and medically attended acute respiratory infections than does pneumococcal conjugate vaccine alone.

Physiologic Effects of an Ambulatory Ventilation System in Chronic Obstructive Pulmonary Disease.

Conclusions: NIOV+O2 yielded substantial exercise endurance improvements accompanied by respiratory muscle unloading and dyspnea reductions in patients with severe hypoxemic COPD. PMID: 23741986 [PubMed - as supplied by publisher] (Source: American Journal of Respiratory and Critical Care Medicine)

The Association of Adiponectin with CT Phenotypes in Chronic Obstructive Pulmonary Disease.

Conclusion: The association between plasma adiponectin and CT-assessed emphysema suggests a contribution of adiponectin to the development of emphysema and highlights a role for metabolic derangements in the pathophysiology of emphysema. PMID: 23777323 [PubMed - as supplied by publisher] (Source: American Journal of Respiratory and Critical Care Medicine)

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor.

Conclusions: These data demonstrate treatment shortening by verapamil adjunctive therapy in mice and strongly support further study of verapamil and other efflux pump inhibitors in human tuberculosis. PMID: 23805786 [PubMed - as supplied by publisher] (Source: American Journal of Respiratory and Critical Care Medicine)

Search